Pay in 4 interest-free payments of $5.15 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Hanmi, Sanfer Partner to Bring GLP-1 Therapy to Mexico Hanmi Pharmaceutical has signed an exclusive distribution agreement with Mexico-based Laboratorios Sanfer to introduce efpeglenatide, a GLP-1 therapy for obesity, alongside Hanmis Dapalon Family diabetes treatments, marking a step in the South Korean companys global expansion strategy focused on metabolic diseases
These are more effective than creams, and there arent any incisions or punctures
As of April 2026, no FDA communication formally distinguishes PDA from BPC-157
DirectMeds Overview DirectMeds has built its brand around two promises: transparent pricing and fast delivery
Healthcare providers may increase the dosage after the initial treatment period based on individual response and tolerability
Nahrungsergnzungsmittel drfen nicht als Ersatz fr eine ausgewogene Ernhrung verwendet werden
